# A Study to Evaluate the Efficacy and Safety of Zingo in Chinese Children

> **NCT03653260** · PHASE3 · COMPLETED · sponsor: **Lee's Pharmaceutical Limited** · enrollment: 288 (actual)

## Conditions studied

- Catheter Site Pain
- Pain, Acute
- Anesthesia, Local

## Interventions

- **DRUG:** Lidocaine (Zingo)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03653260
- **Lead sponsor:** Lee's Pharmaceutical Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-08-15
- **Primary completion:** 2019-02-28
- **Final completion:** 2019-05-21
- **Target enrollment:** 288 (ACTUAL)
- **Last updated:** 2019-09-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03653260

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03653260, "A Study to Evaluate the Efficacy and Safety of Zingo in Chinese Children". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT03653260. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*